Related Experiment Video
Updated: Jul 25, 2026

16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2.
Yu-Wen Hu1, Lynda Rocheleau, Bryce Larke
1Canadian Blood Services, 1800 Alta Vista Drive, Ottawa, Ontario, Canada K1G 4J5. yu-wen.hu@bloodservices.ca
Virology
|February 1, 2005
Summary
Hepatitis C virus (HCV) glycoprotein E2 mimics human antibodies, explaining viral immune evasion and persistent infection. This molecular mimicry advances understanding of viral persistence and host-dependent disease patterns.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) frequently establishes persistent infections.
- Antigenic variation in the E2 glycoprotein's hypervariable region 1 (HVR1) is the accepted mechanism for immune evasion, but doesn't fully explain immune recognition failure.
Purpose of the Study:
- To investigate the structural and antigenic properties of HCV E2 glycoprotein.
- To explore novel mechanisms of viral immune evasion and persistent infection in HCV.
Main Methods:
- Comparative sequence analysis of HCV E2 glycoprotein against human immunoglobulin (Ig) variable domains.
- Utilized position-specific scoring systems to assess sequence similarity.
- Investigated E2 recognition by anti-human IgG antibodies.
Main Results:
- The N-terminal region of HCV E2 exhibits significant antigenic and structural similarity to human Ig variable domains.
- E2 sequences share common features with conserved v-gene framework regions of human Ig light and heavy chains, and T cell receptors.
- The degree of HVR1 similarity to Ig types correlated with viral immune escape and persistence in humans and chimpanzees.
Conclusions:
- HCV E2 employs molecular mimicry of human immunoglobulins as a mechanism for immune evasion.
- This mimicry contributes to the establishment of persistent HCV infections.
- Threshold levels of Ig mimicry may influence host-dependent disease patterns in HCV infection.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

